No Data
No Data
Should You Investigate LeMaitre Vascular, Inc. (NASDAQ:LMAT) At US$94.90?
Fluctuations are expected to continue in the early days of Trump's presidency, with Citigroup favoring Medical, Financial, and other defensive Industries.
In the market volatility and uncertainty following Trump's inauguration, defensive industries such as Medical Care and finance are favored in the model portfolio created by Citigroup strategists.
Declining Stock and Solid Fundamentals: Is The Market Wrong About LeMaitre Vascular, Inc. (NASDAQ:LMAT)?
BDX Stock Down Despite New Expansion to Boost Fingertip Blood Testing
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
LeMaitre Vascular: Estimates Net Proceeds From Offering to Be Approximately $145.9M >LMAT